SlideShare a Scribd company logo
Adding Value through Partnerships: the
MedCity Experience
Professor Simon Howell
Founding Non-Executive Director, MedCity
Director of Academic Estates Strategy for Health Campuses, King’s College London
Within London and the Golden Triangle (London,
Oxford, Cambridge) there is the greatest
concentration of biomedical research capacity in
Europe.
Largest health charity in Europe (Wellcome Trust).
Largest Biomedical Research centre in Europe
(Francis Crick Institute); Sanger Institute.
Independently ranked as the most research
intensive and fastest growing research cluster in
Europe by far.
Major I.T centre of Europe (Google, Cisco,
Microsoft etc – Tech City) – growing convergence.
But only 10% of inward investment of Boston.
The founding members are London’s three
Academic Health Science Centres
 Kings Health Partners
 Imperial College AHSC
 UCLPartners
In conjunction with the office of the Mayor of
London and now in partnership with Oxford
and science centres and institutions across
Cambridge and the broader south-east.
Led by an independent board comprised of
leaders of the major health research
institutions and NHS.
Who set MedCity up?
What does MedCity do?
Catalyse an entrepreneurial culture by championing new areas of
collaboration, and fostering a commercial mind-set in the research
community –both domestically and internationally.
 Bring scientists and businesses of all backgrounds together around
potential areas of collaboration and development
 Assist overseas companies in navigating the major scientific resources that
exist in the south-east – we help make the connections.
 Promote and grow innovation, seed funding, Angel Funding, VC funding.
 Provide guidance on the UK market, accessing the NHS, regulatory
compliance and lessons learned from others.
 Facilitate greater international linkages in the BioSciences and MedTech
fields.
 Link companies to some of the worlds best medical researchers in fields
that matter to both.
Brexit and that stuff
A world leading life-sciences powerhouse built on a longstanding and solid
foundations of international scientific excellence.
 Cambridge University Founded 1209
 Oxford University Founded 1167
 Imperial College – Founded in 1907
 University College London – Founded in 1826
 Kings College London – Founded in 1829
These institutions are not decamping to mainline Europe.
They need clear commitment to free movement of scientists, ideas exchange and
colloboration. Needs continuing access to Horizon 2020, IMI etc.
Global collaborations in all domains of life-sciences including regenerative medicine
and high end medical technologies will continue: ‘Follow the Science’.
What will success look like?
More clinical trials and better recruitment
Corporates and small companies heading to London for early
stage development, manufacture; for trials and SMEs
collaborating with academia and the NHS
More spinouts and more of them staying in London: inward
investment
Global companies moving research facilities to the Golden
Training
Community of life science investors
New, skilled and high-value jobs in London
New therapies and technologies available for patients, faster
CASE STUDY ONE: COLLABORATE TO
INNOVATE
Overview
 “Collaborate to Innovate” promotes collaboration
between SMEs and universities, for knowledge transfer
and commercialisation of innovations in life & health
sciences
 Focuses on the relative lack of investment in research
and innovation by SMEs, due to funding constraints and
lack of awareness of the relevant expertise available
 Addresses a well documented market failure; SMEs
want to work with top London HEIs; but find the process
complicated and inefficient.
Overview
 We will support up to 15 collaborative research projects
between SMEs and Academics, up to £100K each.
 Projects are SME-driven and can be in various domains
such as devices, diagnostics, digital health, and drug
discovery.
 SMEs will be matched with academics with
complementary expertise
 The project costs will be borne by the fund, and no
contribution is required from the SME
Rationale
 Our scheme is driven by the needs of the SME being
met rather than them having to try to fit their plans to a
particular call
 It removes the requirement for matched funding by the
SME
 Ensures every SME innovation/applied research need
has been evaluated and decided to be worth
collaborating on by academic expertise
 Does not duplicate any existing schemes and is
complimentary to the national schemes.
Inputs
 £1.5M for staff time and eligible expenditure to support
15 collaborative research project
 £0.6M for management, support, marketing,
communication, dissemination
50% ERDF
50% Higher Education Funding Council for England
Impacts
 Improving competitiveness of London SMEs in the global
healthcare space
 Promotion of business investment in life sciences
research and innovation as well as technology transfer.
Comparator Study
Maps – London
Location Name Planned Additional Space
(sq. ft.) (2016-17)
Potential Additional Space
(sq. ft.) (2018-20)
1 British Library Site 700,000
2 White City Campus 181,000 355,000+
3 Royal London Hospital Whitechapel 50,000+
4 Royal Street, St Thomas’ Hospital 10,000+
5 Olympicopolis/Pudding Mill 50,000+
6 Royal Marsden/ICR Sutton 900,000+
7 Clare Hall 129,791
Total 181,000 2,144,791
CASE STUDY TWO: INCUBATOR SPACE
DEMAND STUDY
Comparator Study
Maps – New York
Location Name Current Space (sq. ft.) Potential Space (sq. ft.)
1 Harlem Biospace 2,500 15,000
2 Alexandria Centre for Life Sciences 718,000 350,000
3 Audubon Biomedical and Technology
Centre
60,000
4 BioBAT 38,000 85,000
5 SUNY Downstate Advanced Biotech
Incubator
50,000
Total 868,500 450,000
(London 181,000 2,144,791)n
Comparator Study
Maps – Paris
Location Name Current Space (sq. ft.) Potential Space (sq. ft.)
1 Paris Biotech Sante 13,000
2 Agoranov 25,000
3 iPEPS Bioincubator 11,000
4 Villejuif BioPark 57,000
5 Biocitech 215,000
6 Genopole campus 1,100,000
Total 1,421,000
No current
known plans
(London 181,000 2,144,791)n
Comparator Study
Maps – Berlin
Location Name Current Space (sq. ft.) Potential Space (sq. ft.)
1 Berlin BioTech Park Circa 700,000 300,000
2 CoLaborator (Bayer) 9,000
3 Campus Berlin Buch 301,000 Circa 70,000
4 Wulheuide Innovation Park 570,000
5 Berlin Adlershof and IGZ Innovations-
Zentrum
736,000 Circa 50,000
6 Potsdam Biotech Campus 123,000
7 GO:IN Innovation Centre 43,000
8 Dahlem site Circa 50,000
Total 1,922,000 470,000
(London 181,000 2,144,791)n
Comparator Study
Maps – Boston
Location Name Current Space (sq. ft.) Potential Space (sq. ft.)
1 University Park 1,700,000 250,000
2 Lab Central 28,000 60,000
3 Cambridge BioLabs 10,000
4 Technology Square 1,158,000
5 Cambridge Innovation Centre 500,000
6 BioSquare 700,000
7 Umass Venture Development Centre 18,000
8 Mass Innovation Labs 124,000
Total 4,238,000 310,000
(London 181,000 2,144,791)n
Comparator Study
Maps – Boston
Bay Area
Location Name Current Space (sq. ft.) Potential Space (sq. ft.)
1 Cambridge 11,700,000 2,200,000
2 Boston 721,000
3 Inner North 172,000
4 Inner South 1,600,000
5 North I28 2,800,000
6 West I28 1,100,000
7 South I28 668,000
Total 18,760,000 2,200,000
(London 181,000 2,144,791)n
Demand Study Conclusions
 London starts from a low base for Incubation space.
 Substantial growth is planned, which if delivered will rival
Europe’s best : Paris, Berlin, also New York.
 Boston is streets ahead.
MedCity is using ‘Golden Triangle’ as a geographical
template for incubator space going forward
Summary
 MedCity is just over two years old
 It is a thriving infant, with significant early wins: e.g.
Collaborate to Innovate; Demand Study; Oxford and
Cambridge joining.
 A major change has been the realisation that ‘the
competition’ is not in North or West London, but in
Boston, California, Singapore, Shanghai.
 Behaviours and priorities have changed in response to
this.
www.medcityhq.com
office@medcityhq.com or
simon.howell@kcl.ac.uk
www.medcityhq.com
office@medcityhq.com or
simon.howell@kcl.ac.uk

More Related Content

Viewers also liked

Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Biocat, BioRegion of Catalonia
 
Tansforming healthcare condensed
Tansforming healthcare condensedTansforming healthcare condensed
Tansforming healthcare condensed
Neeraj Mahajan
 
Materials u.13
Materials u.13 Materials u.13
Materials u.13
olgacenteno84
 
Manuel Pérez / Founding biotechnology companies
Manuel Pérez / Founding biotechnology companiesManuel Pérez / Founding biotechnology companies
Manuel Pérez / Founding biotechnology companies
Biocat, BioRegion of Catalonia
 
多背一公斤乡村学校水梦想计划
多背一公斤乡村学校水梦想计划多背一公斤乡村学校水梦想计划
多背一公斤乡村学校水梦想计划
vshowyy
 
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume SolàL'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
Biocat, BioRegion of Catalonia
 
Water animals
Water animalsWater animals
Water animals
olgacenteno84
 
MEET mel
MEET melMEET mel
MEET mel
monstart
 
Puzzle Purse
Puzzle PursePuzzle Purse
Puzzle Purse
Joshvan
 
MEET sue
 MEET sue MEET sue
MEET sue
monstart
 
Standard Deviation
Standard DeviationStandard Deviation
Standard Deviation
Miniclebz
 
Webb County
Webb CountyWebb County
Webb County
jakuca
 
Marketing trends maio
Marketing trends maioMarketing trends maio
Marketing trends maio
Francisco Madia
 
Nacco proposal with cover letter
Nacco proposal with cover letterNacco proposal with cover letter
Nacco proposal with cover letter
Neeraj Mahajan
 
Aug 16 workshop backgrounder final
Aug 16 workshop backgrounder finalAug 16 workshop backgrounder final
Aug 16 workshop backgrounder final
Neeraj Mahajan
 
Creative Resume
Creative Resume Creative Resume
Creative Resume
pradeepfx
 
Sources or answer
Sources or answerSources or answer
אוצרות המדעים מצגת הפתרון 1
אוצרות המדעים מצגת הפתרון 1אוצרות המדעים מצגת הפתרון 1
אוצרות המדעים מצגת הפתרון 1eyal2105
 

Viewers also liked (20)

Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
 
Tansforming healthcare condensed
Tansforming healthcare condensedTansforming healthcare condensed
Tansforming healthcare condensed
 
Al Aqsa Arabic
Al Aqsa ArabicAl Aqsa Arabic
Al Aqsa Arabic
 
Materials u.13
Materials u.13 Materials u.13
Materials u.13
 
Manuel Pérez / Founding biotechnology companies
Manuel Pérez / Founding biotechnology companiesManuel Pérez / Founding biotechnology companies
Manuel Pérez / Founding biotechnology companies
 
多背一公斤乡村学校水梦想计划
多背一公斤乡村学校水梦想计划多背一公斤乡村学校水梦想计划
多背一公斤乡村学校水梦想计划
 
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume SolàL'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
L'estratègia d'innovació d'una gran empresa / Gallina Blanca Star, Jaume Solà
 
Water animals
Water animalsWater animals
Water animals
 
MEET mel
MEET melMEET mel
MEET mel
 
Puzzle Purse
Puzzle PursePuzzle Purse
Puzzle Purse
 
MEET sue
 MEET sue MEET sue
MEET sue
 
Standard Deviation
Standard DeviationStandard Deviation
Standard Deviation
 
Alfajr
AlfajrAlfajr
Alfajr
 
Webb County
Webb CountyWebb County
Webb County
 
Marketing trends maio
Marketing trends maioMarketing trends maio
Marketing trends maio
 
Nacco proposal with cover letter
Nacco proposal with cover letterNacco proposal with cover letter
Nacco proposal with cover letter
 
Aug 16 workshop backgrounder final
Aug 16 workshop backgrounder finalAug 16 workshop backgrounder final
Aug 16 workshop backgrounder final
 
Creative Resume
Creative Resume Creative Resume
Creative Resume
 
Sources or answer
Sources or answerSources or answer
Sources or answer
 
אוצרות המדעים מצגת הפתרון 1
אוצרות המדעים מצגת הפתרון 1אוצרות המדעים מצגת הפתרון 1
אוצרות המדעים מצגת הפתרון 1
 

Similar to “Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL

Imagine your life sciences business in London
Imagine your life sciences business in LondonImagine your life sciences business in London
Imagine your life sciences business in London
londonandpartners
 
Embedding impact in a Biomedical Research Centre through partnerships
Embedding impact in a Biomedical Research Centre through partnershipsEmbedding impact in a Biomedical Research Centre through partnerships
Embedding impact in a Biomedical Research Centre through partnerships
Pavel Ovseiko
 
Prague lecture
Prague lecturePrague lecture
Prague lecture
Lorraine Warren
 
G V L Berkeley University College London Schooling
G V L  Berkeley  University  College  London  SchoolingG V L  Berkeley  University  College  London  Schooling
G V L Berkeley University College London Schooling
Center for Entrepreneurship & Technology, University of California, Berkeley
 
Dr. Henshall slides TiE July 14 event
Dr. Henshall slides TiE July 14 eventDr. Henshall slides TiE July 14 event
Dr. Henshall slides TiE July 14 event
tushargupta081165
 
ECH Campus Leadership Summit: Alastair Hamilton
ECH Campus Leadership Summit: Alastair HamiltonECH Campus Leadership Summit: Alastair Hamilton
ECH Campus Leadership Summit: Alastair Hamilton
3GDR
 
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
David Bembo
 
Xiang Cam Tcm Research Centre
Xiang Cam Tcm Research CentreXiang Cam Tcm Research Centre
Xiang Cam Tcm Research Centre
East of England International
 
Xiang Cam Tcm Research Centre
Xiang Cam Tcm Research CentreXiang Cam Tcm Research Centre
Xiang Cam Tcm Research Centre
RichardPike
 
The collaborative approach as a key factor to attract private investments for...
The collaborative approach as a key factor to attract private investments for...The collaborative approach as a key factor to attract private investments for...
The collaborative approach as a key factor to attract private investments for...
InvestinLombardy
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum
 
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
David Bembo
 
RCUK Strategy
RCUK StrategyRCUK Strategy
RCUK Strategy
steven_hill
 
PR_2016-11-10_Lab282_Evotec_e
PR_2016-11-10_Lab282_Evotec_ePR_2016-11-10_Lab282_Evotec_e
PR_2016-11-10_Lab282_Evotec_e
Thomas Hanke
 
Realizing a UK National Compound Collection
Realizing a UK National Compound CollectionRealizing a UK National Compound Collection
Realizing a UK National Compound Collection
Royal Society of Chemistry
 
Life sciences JustAsk
Life sciences JustAskLife sciences JustAsk
Life sciences JustAsk
Katelin Hughes
 
innovationuk
innovationukinnovationuk
innovationuk
Jennifer Gristock
 
SWLP Opening
SWLP OpeningSWLP Opening
SWLP Opening
Chris Hunton
 
Uppsala BIO - An agent of change
Uppsala BIO - An agent of changeUppsala BIO - An agent of change
Uppsala BIO - An agent of change
Robin Teigland
 
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
Robin Teigland
 

Similar to “Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL (20)

Imagine your life sciences business in London
Imagine your life sciences business in LondonImagine your life sciences business in London
Imagine your life sciences business in London
 
Embedding impact in a Biomedical Research Centre through partnerships
Embedding impact in a Biomedical Research Centre through partnershipsEmbedding impact in a Biomedical Research Centre through partnerships
Embedding impact in a Biomedical Research Centre through partnerships
 
Prague lecture
Prague lecturePrague lecture
Prague lecture
 
G V L Berkeley University College London Schooling
G V L  Berkeley  University  College  London  SchoolingG V L  Berkeley  University  College  London  Schooling
G V L Berkeley University College London Schooling
 
Dr. Henshall slides TiE July 14 event
Dr. Henshall slides TiE July 14 eventDr. Henshall slides TiE July 14 event
Dr. Henshall slides TiE July 14 event
 
ECH Campus Leadership Summit: Alastair Hamilton
ECH Campus Leadership Summit: Alastair HamiltonECH Campus Leadership Summit: Alastair Hamilton
ECH Campus Leadership Summit: Alastair Hamilton
 
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
UK Knowledge Exchange, TechnologieAllianz, Berlin 16.04.2013
 
Xiang Cam Tcm Research Centre
Xiang Cam Tcm Research CentreXiang Cam Tcm Research Centre
Xiang Cam Tcm Research Centre
 
Xiang Cam Tcm Research Centre
Xiang Cam Tcm Research CentreXiang Cam Tcm Research Centre
Xiang Cam Tcm Research Centre
 
The collaborative approach as a key factor to attract private investments for...
The collaborative approach as a key factor to attract private investments for...The collaborative approach as a key factor to attract private investments for...
The collaborative approach as a key factor to attract private investments for...
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
An update on UK Knowledge Exchange, ProTon, Liege 20.09.2012
 
RCUK Strategy
RCUK StrategyRCUK Strategy
RCUK Strategy
 
PR_2016-11-10_Lab282_Evotec_e
PR_2016-11-10_Lab282_Evotec_ePR_2016-11-10_Lab282_Evotec_e
PR_2016-11-10_Lab282_Evotec_e
 
Realizing a UK National Compound Collection
Realizing a UK National Compound CollectionRealizing a UK National Compound Collection
Realizing a UK National Compound Collection
 
Life sciences JustAsk
Life sciences JustAskLife sciences JustAsk
Life sciences JustAsk
 
innovationuk
innovationukinnovationuk
innovationuk
 
SWLP Opening
SWLP OpeningSWLP Opening
SWLP Opening
 
Uppsala BIO - An agent of change
Uppsala BIO - An agent of changeUppsala BIO - An agent of change
Uppsala BIO - An agent of change
 
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
Improving Regional Competitiveness: The Vinnväxt Program and Uppsala BIO – th...
 

More from Biocat, BioRegion of Catalonia

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
Biocat, BioRegion of Catalonia
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
Biocat, BioRegion of Catalonia
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
Biocat, BioRegion of Catalonia
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
Biocat, BioRegion of Catalonia
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
Biocat, BioRegion of Catalonia
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
Biocat, BioRegion of Catalonia
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Biocat, BioRegion of Catalonia
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Biocat, BioRegion of Catalonia
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
Biocat, BioRegion of Catalonia
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Biocat, BioRegion of Catalonia
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Biocat, BioRegion of Catalonia
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
Biocat, BioRegion of Catalonia
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
Biocat, BioRegion of Catalonia
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
Biocat, BioRegion of Catalonia
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
Biocat, BioRegion of Catalonia
 
HEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATINGHEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATING
Biocat, BioRegion of Catalonia
 
The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015
Biocat, BioRegion of Catalonia
 
Iñaki Largo / Univalue G9-Bilbao
Iñaki Largo / Univalue G9-BilbaoIñaki Largo / Univalue G9-Bilbao
Iñaki Largo / Univalue G9-Bilbao
Biocat, BioRegion of Catalonia
 

More from Biocat, BioRegion of Catalonia (20)

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
 
HEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATINGHEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATING
 
The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015
 
Iñaki Largo / Univalue G9-Bilbao
Iñaki Largo / Univalue G9-BilbaoIñaki Largo / Univalue G9-Bilbao
Iñaki Largo / Univalue G9-Bilbao
 

Recently uploaded

vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 

Recently uploaded (20)

vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 

“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL

  • 1. Adding Value through Partnerships: the MedCity Experience Professor Simon Howell Founding Non-Executive Director, MedCity Director of Academic Estates Strategy for Health Campuses, King’s College London
  • 2. Within London and the Golden Triangle (London, Oxford, Cambridge) there is the greatest concentration of biomedical research capacity in Europe. Largest health charity in Europe (Wellcome Trust). Largest Biomedical Research centre in Europe (Francis Crick Institute); Sanger Institute. Independently ranked as the most research intensive and fastest growing research cluster in Europe by far. Major I.T centre of Europe (Google, Cisco, Microsoft etc – Tech City) – growing convergence. But only 10% of inward investment of Boston.
  • 3. The founding members are London’s three Academic Health Science Centres  Kings Health Partners  Imperial College AHSC  UCLPartners In conjunction with the office of the Mayor of London and now in partnership with Oxford and science centres and institutions across Cambridge and the broader south-east. Led by an independent board comprised of leaders of the major health research institutions and NHS. Who set MedCity up?
  • 4. What does MedCity do? Catalyse an entrepreneurial culture by championing new areas of collaboration, and fostering a commercial mind-set in the research community –both domestically and internationally.  Bring scientists and businesses of all backgrounds together around potential areas of collaboration and development  Assist overseas companies in navigating the major scientific resources that exist in the south-east – we help make the connections.  Promote and grow innovation, seed funding, Angel Funding, VC funding.  Provide guidance on the UK market, accessing the NHS, regulatory compliance and lessons learned from others.  Facilitate greater international linkages in the BioSciences and MedTech fields.  Link companies to some of the worlds best medical researchers in fields that matter to both.
  • 5. Brexit and that stuff A world leading life-sciences powerhouse built on a longstanding and solid foundations of international scientific excellence.  Cambridge University Founded 1209  Oxford University Founded 1167  Imperial College – Founded in 1907  University College London – Founded in 1826  Kings College London – Founded in 1829 These institutions are not decamping to mainline Europe. They need clear commitment to free movement of scientists, ideas exchange and colloboration. Needs continuing access to Horizon 2020, IMI etc. Global collaborations in all domains of life-sciences including regenerative medicine and high end medical technologies will continue: ‘Follow the Science’.
  • 6. What will success look like? More clinical trials and better recruitment Corporates and small companies heading to London for early stage development, manufacture; for trials and SMEs collaborating with academia and the NHS More spinouts and more of them staying in London: inward investment Global companies moving research facilities to the Golden Training Community of life science investors New, skilled and high-value jobs in London New therapies and technologies available for patients, faster
  • 7. CASE STUDY ONE: COLLABORATE TO INNOVATE Overview  “Collaborate to Innovate” promotes collaboration between SMEs and universities, for knowledge transfer and commercialisation of innovations in life & health sciences  Focuses on the relative lack of investment in research and innovation by SMEs, due to funding constraints and lack of awareness of the relevant expertise available  Addresses a well documented market failure; SMEs want to work with top London HEIs; but find the process complicated and inefficient.
  • 8. Overview  We will support up to 15 collaborative research projects between SMEs and Academics, up to £100K each.  Projects are SME-driven and can be in various domains such as devices, diagnostics, digital health, and drug discovery.  SMEs will be matched with academics with complementary expertise  The project costs will be borne by the fund, and no contribution is required from the SME
  • 9. Rationale  Our scheme is driven by the needs of the SME being met rather than them having to try to fit their plans to a particular call  It removes the requirement for matched funding by the SME  Ensures every SME innovation/applied research need has been evaluated and decided to be worth collaborating on by academic expertise  Does not duplicate any existing schemes and is complimentary to the national schemes.
  • 10. Inputs  £1.5M for staff time and eligible expenditure to support 15 collaborative research project  £0.6M for management, support, marketing, communication, dissemination 50% ERDF 50% Higher Education Funding Council for England
  • 11. Impacts  Improving competitiveness of London SMEs in the global healthcare space  Promotion of business investment in life sciences research and innovation as well as technology transfer.
  • 12. Comparator Study Maps – London Location Name Planned Additional Space (sq. ft.) (2016-17) Potential Additional Space (sq. ft.) (2018-20) 1 British Library Site 700,000 2 White City Campus 181,000 355,000+ 3 Royal London Hospital Whitechapel 50,000+ 4 Royal Street, St Thomas’ Hospital 10,000+ 5 Olympicopolis/Pudding Mill 50,000+ 6 Royal Marsden/ICR Sutton 900,000+ 7 Clare Hall 129,791 Total 181,000 2,144,791 CASE STUDY TWO: INCUBATOR SPACE DEMAND STUDY
  • 13. Comparator Study Maps – New York Location Name Current Space (sq. ft.) Potential Space (sq. ft.) 1 Harlem Biospace 2,500 15,000 2 Alexandria Centre for Life Sciences 718,000 350,000 3 Audubon Biomedical and Technology Centre 60,000 4 BioBAT 38,000 85,000 5 SUNY Downstate Advanced Biotech Incubator 50,000 Total 868,500 450,000 (London 181,000 2,144,791)n
  • 14. Comparator Study Maps – Paris Location Name Current Space (sq. ft.) Potential Space (sq. ft.) 1 Paris Biotech Sante 13,000 2 Agoranov 25,000 3 iPEPS Bioincubator 11,000 4 Villejuif BioPark 57,000 5 Biocitech 215,000 6 Genopole campus 1,100,000 Total 1,421,000 No current known plans (London 181,000 2,144,791)n
  • 15. Comparator Study Maps – Berlin Location Name Current Space (sq. ft.) Potential Space (sq. ft.) 1 Berlin BioTech Park Circa 700,000 300,000 2 CoLaborator (Bayer) 9,000 3 Campus Berlin Buch 301,000 Circa 70,000 4 Wulheuide Innovation Park 570,000 5 Berlin Adlershof and IGZ Innovations- Zentrum 736,000 Circa 50,000 6 Potsdam Biotech Campus 123,000 7 GO:IN Innovation Centre 43,000 8 Dahlem site Circa 50,000 Total 1,922,000 470,000 (London 181,000 2,144,791)n
  • 16. Comparator Study Maps – Boston Location Name Current Space (sq. ft.) Potential Space (sq. ft.) 1 University Park 1,700,000 250,000 2 Lab Central 28,000 60,000 3 Cambridge BioLabs 10,000 4 Technology Square 1,158,000 5 Cambridge Innovation Centre 500,000 6 BioSquare 700,000 7 Umass Venture Development Centre 18,000 8 Mass Innovation Labs 124,000 Total 4,238,000 310,000 (London 181,000 2,144,791)n
  • 17. Comparator Study Maps – Boston Bay Area Location Name Current Space (sq. ft.) Potential Space (sq. ft.) 1 Cambridge 11,700,000 2,200,000 2 Boston 721,000 3 Inner North 172,000 4 Inner South 1,600,000 5 North I28 2,800,000 6 West I28 1,100,000 7 South I28 668,000 Total 18,760,000 2,200,000 (London 181,000 2,144,791)n
  • 18. Demand Study Conclusions  London starts from a low base for Incubation space.  Substantial growth is planned, which if delivered will rival Europe’s best : Paris, Berlin, also New York.  Boston is streets ahead. MedCity is using ‘Golden Triangle’ as a geographical template for incubator space going forward
  • 19. Summary  MedCity is just over two years old  It is a thriving infant, with significant early wins: e.g. Collaborate to Innovate; Demand Study; Oxford and Cambridge joining.  A major change has been the realisation that ‘the competition’ is not in North or West London, but in Boston, California, Singapore, Shanghai.  Behaviours and priorities have changed in response to this.